Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18642830rdf:typepubmed:Citationlld:pubmed
pubmed-article:18642830lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:18642830lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:18642830lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:18642830lifeskim:mentionsumls-concept:C1443643lld:lifeskim
pubmed-article:18642830lifeskim:mentionsumls-concept:C0376211lld:lifeskim
pubmed-article:18642830lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:18642830lifeskim:mentionsumls-concept:C0439185lld:lifeskim
pubmed-article:18642830lifeskim:mentionsumls-concept:C0439836lld:lifeskim
pubmed-article:18642830lifeskim:mentionsumls-concept:C1880371lld:lifeskim
pubmed-article:18642830lifeskim:mentionsumls-concept:C0913167lld:lifeskim
pubmed-article:18642830pubmed:issue16lld:pubmed
pubmed-article:18642830pubmed:dateCreated2008-8-8lld:pubmed
pubmed-article:18642830pubmed:abstractTextA series of chiral 2,3- and 3,4-methanoamino acid equivalents of stereochemical diversity were designed and synthesized from our chiral cyclopropane units, using a diastereoselective Grignard addition with ( R)- or ( S)- t-butanesulfinyl imines as the key step. These equivalents were converted into the proteasome inhibitor belactosin A and its cis-cyclopropane stereoisomer. The unnatural cis-isomer was shown to be more than twice as potent as belactosin A as a proteasome inhibitor.lld:pubmed
pubmed-article:18642830pubmed:languageenglld:pubmed
pubmed-article:18642830pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18642830pubmed:citationSubsetIMlld:pubmed
pubmed-article:18642830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18642830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18642830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18642830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18642830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18642830pubmed:statusMEDLINElld:pubmed
pubmed-article:18642830pubmed:monthAuglld:pubmed
pubmed-article:18642830pubmed:issn1523-7052lld:pubmed
pubmed-article:18642830pubmed:authorpubmed-author:MatsudaAkiraAlld:pubmed
pubmed-article:18642830pubmed:authorpubmed-author:ShutoSatoshiSlld:pubmed
pubmed-article:18642830pubmed:authorpubmed-author:YokosawaHidey...lld:pubmed
pubmed-article:18642830pubmed:authorpubmed-author:YamaguchiKazu...lld:pubmed
pubmed-article:18642830pubmed:authorpubmed-author:UnnoYukaYlld:pubmed
pubmed-article:18642830pubmed:authorpubmed-author:SoneTakayukiTlld:pubmed
pubmed-article:18642830pubmed:authorpubmed-author:AsaiAkiraAlld:pubmed
pubmed-article:18642830pubmed:authorpubmed-author:ArisawaMitsuh...lld:pubmed
pubmed-article:18642830pubmed:authorpubmed-author:YoshidaKeisuk...lld:pubmed
pubmed-article:18642830pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18642830pubmed:day21lld:pubmed
pubmed-article:18642830pubmed:volume10lld:pubmed
pubmed-article:18642830pubmed:ownerNLMlld:pubmed
pubmed-article:18642830pubmed:authorsCompleteYlld:pubmed
pubmed-article:18642830pubmed:pagination3571-4lld:pubmed
pubmed-article:18642830pubmed:meshHeadingpubmed-meshheading:18642830...lld:pubmed
pubmed-article:18642830pubmed:meshHeadingpubmed-meshheading:18642830...lld:pubmed
pubmed-article:18642830pubmed:meshHeadingpubmed-meshheading:18642830...lld:pubmed
pubmed-article:18642830pubmed:meshHeadingpubmed-meshheading:18642830...lld:pubmed
pubmed-article:18642830pubmed:meshHeadingpubmed-meshheading:18642830...lld:pubmed
pubmed-article:18642830pubmed:meshHeadingpubmed-meshheading:18642830...lld:pubmed
pubmed-article:18642830pubmed:year2008lld:pubmed
pubmed-article:18642830pubmed:articleTitleSynthesis of 2,3- and 3,4-methanoamino acid equivalents with stereochemical diversity and their conversion into the tripeptide proteasome inhibitor belactosin a and its highly potent cis-cyclopropane stereoisomer.lld:pubmed
pubmed-article:18642830pubmed:affiliationFaculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.lld:pubmed
pubmed-article:18642830pubmed:publicationTypeJournal Articlelld:pubmed